Nephropathy clinical trials
20 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Atacicept in Multiple Glomerular Diseases
- Amnioinfusion for Fetal Renal Failure
- Inspire HER: Inspiring the Heart and Emotions for Radical Health
- Rutgers University Study of the Genetics of Kidney Disease
- Duke APOL1 Research Biorepository
- LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study
- The Effects of the CF Carrier State on the Kidneys and Pancreas
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
- Immune System Related Kidney Disease
- A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
- Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
- NightWare and Cardiovascular Health in Women With PTSD
- Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
- UCLA Magnesium Formulation Athlete Study
- Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans
- Biorepository to Support Research in Kidney Diseases
- AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
- Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
- APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Nephropathy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.